Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics-Reference-Cited by-同舟云学术

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics

Published:2013-03-07 Issue:1 Volume:13 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Arbring Kerstin,Uppugunduri Srinivas,Lindahl Tomas L

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/article/10.1186/1472-6963-13-85/fulltext.html

Reference11 articles.

1. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G: Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141: e44S-e88S. 10.1378/chest.11-2292.

2. White HD, Gruber M, Feyzi J, Kaatz S, Tse H-F, Husted S, Albers GW: Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007, 167: 239-245. 10.1001/archinte.167.3.239.

3. Veeger NJGM, Piersma-Wichers M, Tijssen JGP, Hillege HL, van der Meer J: Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol. 2005, 128: 513-519. 10.1111/j.1365-2141.2004.05348.x.

4. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH: Evidence-Based Management of Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012, 141: e152S-e184S. 10.1378/chest.11-2295.

5. Rose AJ, Ozonoff A, Henault LE, Hylek EM: Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost. 2008, 6: 1647-1654. 10.1111/j.1538-7836.2008.03075.x.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity;Thrombosis Research;2021-07

2. Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation;Frontiers in Pharmacology;2021-04-26

3. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy;Blood Advances;2018-11-27

4. Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings;BMC Health Services Research;2018-09-19

5. Clinically relevant drug–drug interactions among elderly people with dementia;European Journal of Clinical Pharmacology;2018-07-02